ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/17 | 1,561 | 1,580 | 1,515 | 1,524 | -33 | -2.1% | 726,600 |
2020/07/16 | 1,565 | 1,600 | 1,557 | 1,557 | -5 | -0.3% | 791,900 |
2020/07/15 | 1,553 | 1,572 | 1,552 | 1,562 | +23 | +1.5% | 493,100 |
2020/07/14 | 1,556 | 1,575 | 1,539 | 1,539 | -20 | -1.3% | 314,500 |
2020/07/13 | 1,544 | 1,570 | 1,514 | 1,559 | +37 | +2.4% | 564,500 |
2020/07/10 | 1,545 | 1,585 | 1,503 | 1,522 | -22 | -1.4% | 881,000 |
2020/07/09 | 1,579 | 1,580 | 1,544 | 1,544 | -18 | -1.2% | 589,300 |
2020/07/08 | 1,553 | 1,588 | 1,544 | 1,562 | +12 | +0.8% | 774,600 |
2020/07/07 | 1,531 | 1,600 | 1,506 | 1,550 | +13 | +0.8% | 1,508,800 |
2020/07/06 | 1,517 | 1,571 | 1,517 | 1,537 | +26 | +1.7% | 727,900 |
2020/07/03 | 1,527 | 1,543 | 1,493 | 1,511 | -16 | -1% | 1,073,700 |
2020/07/02 | 1,580 | 1,601 | 1,500 | 1,527 | -33 | -2.1% | 2,112,600 |
2020/07/01 | 1,597 | 1,620 | 1,556 | 1,560 | -174 | -10% | 3,867,300 |
2020/06/30 | 1,755 | 1,762 | 1,660 | 1,734 | +25 | +1.5% | 1,432,700 |
2020/06/29 | 1,825 | 1,830 | 1,700 | 1,709 | -140 | -7.6% | 1,791,700 |
2020/06/26 | 1,890 | 1,956 | 1,822 | 1,849 | -28 | -1.5% | 4,219,200 |
2020/06/25 | 1,665 | 1,937 | 1,653 | 1,877 | +207 | +12.4% | 7,963,600 |
2020/06/24 | 1,697 | 1,700 | 1,657 | 1,670 | -23 | -1.4% | 638,000 |
2020/06/23 | 1,730 | 1,733 | 1,671 | 1,693 | -33 | -1.9% | 718,000 |
2020/06/22 | 1,728 | 1,745 | 1,702 | 1,726 | +9 | +0.5% | 475,200 |
2020/06/19 | 1,727 | 1,727 | 1,683 | 1,717 | +5 | +0.3% | 453,400 |
2020/06/18 | 1,708 | 1,733 | 1,689 | 1,712 | +14 | +0.8% | 419,700 |
2020/06/17 | 1,700 | 1,723 | 1,675 | 1,698 | +9 | +0.5% | 577,300 |
2020/06/16 | 1,640 | 1,695 | 1,633 | 1,689 | +105 | +6.6% | 662,000 |
2020/06/15 | 1,650 | 1,693 | 1,575 | 1,584 | -49 | -3% | 886,800 |
2020/06/12 | 1,611 | 1,672 | 1,589 | 1,633 | -87 | -5.1% | 1,198,700 |
2020/06/11 | 1,801 | 1,814 | 1,718 | 1,720 | -88 | -4.9% | 1,054,900 |
2020/06/10 | 1,774 | 1,810 | 1,766 | 1,808 | +17 | +0.9% | 808,300 |
2020/06/09 | 1,790 | 1,808 | 1,756 | 1,791 | -9 | -0.5% | 761,800 |
2020/06/08 | 1,837 | 1,860 | 1,734 | 1,800 | -53 | -2.9% | 2,336,300 |
2020/06/05 | 1,732 | 1,971 | 1,719 | 1,853 | +116 | +6.7% | 4,040,500 |
2020/06/04 | 1,790 | 1,804 | 1,716 | 1,737 | -46 | -2.6% | 909,300 |
2020/06/03 | 1,798 | 1,798 | 1,764 | 1,783 | -8 | -0.4% | 672,200 |
2020/06/02 | 1,800 | 1,810 | 1,771 | 1,791 | +6 | +0.3% | 543,200 |
2020/06/01 | 1,793 | 1,794 | 1,761 | 1,785 | -33 | -1.8% | 789,000 |
2020/05/29 | 1,803 | 1,860 | 1,797 | 1,818 | +54 | +3.1% | 1,577,900 |
2020/05/28 | 1,795 | 1,811 | 1,726 | 1,764 | -28 | -1.6% | 890,000 |
2020/05/27 | 1,777 | 1,804 | 1,750 | 1,792 | -3 | -0.2% | 713,800 |
2020/05/26 | 1,812 | 1,826 | 1,782 | 1,795 | -7 | -0.4% | 725,000 |
2020/05/25 | 1,791 | 1,841 | 1,791 | 1,802 | +8 | +0.4% | 824,700 |
2020/05/22 | 1,814 | 1,829 | 1,781 | 1,794 | -31 | -1.7% | 747,700 |
2020/05/21 | 1,830 | 1,857 | 1,809 | 1,825 | -31 | -1.7% | 1,044,200 |
2020/05/20 | 1,800 | 1,866 | 1,788 | 1,856 | +56 | +3.1% | 1,088,500 |
2020/05/19 | 1,820 | 1,828 | 1,756 | 1,800 | +11 | +0.6% | 1,313,300 |
2020/05/18 | 1,732 | 1,832 | 1,722 | 1,789 | +102 | +6% | 1,996,300 |
2020/05/15 | 1,630 | 1,714 | 1,611 | 1,687 | +94 | +5.9% | 1,369,300 |
2020/05/14 | 1,550 | 1,663 | 1,521 | 1,593 | +24 | +1.5% | 2,363,400 |
2020/05/13 | 1,550 | 1,586 | 1,544 | 1,569 | +7 | +0.4% | 777,300 |
2020/05/12 | 1,540 | 1,572 | 1,530 | 1,562 | +32 | +2.1% | 758,000 |
2020/05/11 | 1,518 | 1,549 | 1,500 | 1,530 | +12 | +0.8% | 871,900 |
1201~
1250
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム